Tim Healey, the marketer at the helm during the hugely successful launch of sleep aid Lunesta, has left Sepracor to join Cambridge, MA, iron oxide nanoparticle firm Advanced Magnetics.
Healey worked at Sepracor in various roles since 2001, most recently as executive director of CNS marketing.
In 2005, Healey led the marketing charge behind the Lunesta launch. Facing stiff competition from Sanofi-Aventis’ Ambien, Lunesta achieved sales of approximately $465 million during its first year.
As a result, Healey’s work was acknowledged with several industry awards.
In January, the Lunesta marketing team was recognized as MM&M’s “Marketing Team of the Year.” The team also picked up a Gold Award at the 2005 MM&M Awards.
In his new role, as SVP of commercial operations at Advanced Magnetics, Healey will be responsible for developing and implementing sales and marketing strategies for all of Advanced Magnetics’ products and product candidates.
Those products include Feridex IV an agent for use with MRI for the detection of liver lesions; Ferumoxytol, a Phase III iron replacement therapeutic for chronic kidney disease patients and the investigational compound Combidex, a molecular imaging agent for use in conjunction with magnetic resonance imaging.